Tech Edge hosted a fireside chat on April 22 at Nasdaq MarketSite with Jason Matuszewski, Chief Executive Officer of BioStem Technologies, Inc. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed why the company’s 2024 revenue surged 18x, BioStem’s planned NASDAQ uplisting, what makes VENDAJE AC and AmnioWrap2 stand out in the wound care space, and more.
Watch the interview below:
About Jason Matuszewski
https://biostemtechnologies.com/?sptp_member=jason-matuszewski&preview=true
About BioStem Technologies, Inc.
https://biostemtechnologies.com/
Contact:
